CICC: Lowering the forecast for Fed rate cuts this year to once
CICC Research indicates that since this year, the pace of inflation slowdown in the United States has decelerated, the labor market remains strong, consumer spending is robust, and real estate and manufacturing are recovering. At the same time, financial conditions remain loose, corporate financing costs have decreased, and impressive stock market performance supports expansion of household wealth. From an economic fundamentals perspective, we believe that the urgency and necessity for the Federal Reserve to cut interest rates have declined. It may be difficult for the Fed to follow its guidance of three rate cuts this year; therefore we lower our forecast for rate cuts to once with a possible delay until Q4. However, as it's an election year unpredictable non-economic factors could disrupt predictions; there's risk that these factors might prompt earlier rate cuts by Fed. But history shows such actions can easily trigger "second-round inflation", adding complexity to subsequent economic trends and policy directions.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bitcoin Trades Around $86K as FOMO Hits Highest Level Since 2024

siRNA rising star ADARx (ADRX.US) launches $350 millions IPO, AbbVie subscribes to 4.9% of shares with a maximum investment of $100 millions
ADARx plans to raise $350 millions and list on Nasdaq. AbbVie will invest up to $100 millions to acquire a 4.9% stake, with a median valuation of $1.8 billions.
Roche (RHHBY.US) weight loss injection shows positive mid-term trial results: average weight loss of 15.5% over 48 weeks, blood sugar levels drop by 2.65%.
The experimental weight-loss injection enicepatide simultaneously lowered blood sugar and body weight in overweight or obese patients with type 2 diabetes during a mid-stage clinical trial.
SPAC company Silicon Valley Acquisition II (SVATU.US) applies for US stock IPO, aiming to raise up to 220 millions USD.
The blank-check company (SPAC) Silicon Valley Acquisition II submitted a filing to the U.S. Securities and Exchange Commission (SEC) on Monday, planning to raise up to 220 millions USD through an initial public offering (IPO).